Beta-catenin is a protein found in almost every cell in the body. It does two jobs. It helps hold neighboring cells together at their surfaces. It also carries growth signals from the surface of a cell into the nucleus, the compartment where the genetic material is kept.
Pathologists test for beta-catenin using a stain applied to tissue. What matters is not simply whether the protein is present, since it is present in normal cells too, but where inside the cell it is found. The report describes that location.
What does beta-catenin normally do?
In a healthy cell, beta-catenin sits mainly at the cell surface, helping to anchor the cell to its neighbors. A small amount travels inside the cell to deliver a growth signal, and the cell then breaks that amount down promptly so the signal does not continue.
The system that breaks it down involves several other proteins, including one made by the APC gene. When either the beta-catenin gene itself, called CTNNB1, or one of the genes controlling its breakdown is changed, beta-catenin is no longer removed. It builds up and moves into the nucleus, where it switches on growth signals continuously. This is the abnormality the stain is looking for.
How is beta-catenin tested and reported?
Beta-catenin is detected using immunohistochemistry, a test that uses antibodies to find a specific protein in a tissue sample. Where the protein is present, the cells take up a colored stain that the pathologist can see under the microscope.
The report describes the pattern rather than a simple positive or negative.
- Membranous staining. The stain outlines the edges of the cells. This is the normal pattern and is what healthy tissue shows.
- Nuclear staining. The stain is seen inside the nucleus. This is the abnormal pattern, and it indicates that the growth pathway is switched on. Reports may describe this as nuclear expression, nuclear reactivity, or abnormal beta-catenin.
- Cytoplasmic staining. The stain is seen in the cell body. This is often described alongside nuclear staining and points in the same direction.
Because the normal pattern is also positive, “beta-catenin positive” on its own does not tell you much. The useful phrase to look for in the report is nuclear or abnormal.
Which tumors show abnormal beta-catenin?
Nuclear beta-catenin is characteristic of a specific group of tumors. Finding it can confirm a diagnosis, and its absence can help rule one out.
- Hepatoblastoma. The commonest liver cancer of childhood. Most carry a CTNNB1 change and show nuclear staining.
- Desmoid fibromatosis. A growth of fibrous tissue that can grow into nearby structures but does not spread elsewhere in the body.
- Solid pseudopapillary neoplasm of the pancreas. An uncommon pancreatic tumor seen mainly in young women.
- Medulloblastoma. Nuclear beta-catenin identifies the WNT-activated group, which has the most favorable outlook of the medulloblastoma groups.
- Craniopharyngioma. The adamantinomatous type, a brain tumor seen mainly in children.
- Some carcinomas of the uterus and other organs. Where the result is used alongside other findings rather than on its own.
Does an abnormal beta-catenin result mean the change is inherited?
Usually not. Most CTNNB1 changes are acquired during life within the tumor itself and are not present in the body’s other cells. They are not passed to children.
One important connection is inherited disease. The APC gene helps break beta-catenin down, and people with familial adenomatous polyposis are born with a change in APC. Their cells therefore accumulate beta-catenin for a different reason, and this is part of why that condition raises the risk of bowel polyps, desmoid fibromatosis, and hepatoblastoma in early childhood. An abnormal beta-catenin stain does not, by itself, mean an inherited condition is present, but in certain tumors it may raise the question.
Questions to ask your doctor
- Was a beta-catenin stain performed on my tissue sample?
- Was the staining pattern membranous, which is normal, or nuclear, which is abnormal?
- How does this result support or change my diagnosis?
- Was the CTNNB1 gene itself tested, and what did that show?
- Does this result affect my treatment or my prognosis?
- Does this finding raise any possibility of an inherited condition in my family?
- Should anyone else in my family be tested or assessed?
Related articles on MyPathologyReport.com
We are proud to partner with:
🔍 Search MyPathologyReport
Type what you see on your report — for example a diagnosis or test name